Nachrichten zur Guardant Health Inc. Aktie

Guardant Health, Inc. (GH) Q3 2025 Earnings Call Transcript

…

Guardant Health (GH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Guardant Health (GH) give insight into how the company performed in the quarter ended September 2025,…

Guardant Health (GH) Reports Q3 Loss, Beats Revenue Estimates

Guardant Health (GH) delivered earnings and revenue surprises of +18.75% and +13.05%, respectively, for the quarter ended September 2025. Do…

Guardant Health (GH) Q3 2025 Earnings Transcript

Image source: The Motley Fool.DATEWednesday, Oct. 29, 2025 at 4:30 p.m. ETCALL PARTICIPANTSCo-Chief Executive Officer — Helmy EltoukhyCo-Chief Executive Officer…

Guardant Health und Kooperationspartner präsentieren auf der ESMO 2025 neue Daten zur gesamten Krebsbehandlungskette

PALO ALTO, Kalifornien--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), ein führendes Unternehmen im Bereich der Präzisionsonkologie, gab heute bekannt, dass neue…

Guardant Health: Hold Rating Ahead Of Q3 Results On Valuation And Execution Risk

…

Die stille Revolution der Krebserkennung: Wie Guardant Health den Kampf gegen den Krebs neu definiert

Guardant Health ist ein führender Anbieter im zukunftsweisenden Bereich der Flüssigbiopsie, einer minimalinvasiven Methode zur Krebserkennung und -überwachung, die…

Guardant Health - Anziehende Patientenzahlen bescheren Diagnostik-Spezialisten starke Aussichten

Geschäftstreiber: Guardant Health (GH) sich auf die Entwicklung und Vermarktung von Bluttests zur Krebserkennung und -überwachung spezialisiert. Mithilfe sogenannter "flüssiger…

Guardant Health und James Van Der Beek schließen sich zusammen, um das Bewusstsein für neue Fortschritte bei der Darmkrebsvorsorge für Erwachsene ab 45 Jahren zu schärfen

PALO ALTO, Kalifornien--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), ein führendes Unternehmen im Bereich der Präzisionsonkologie, gab heute seine Partnerschaft mit…

Guardant Health (GH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Guardant Health (GH) give a sense of how its business performed in the quarter…

Guardant Health (GH) Reports Q2 Loss, Beats Revenue Estimates

Guardant Health (GH) delivered earnings and revenue surprises of +15.38% and +9.77%, respectively, for the quarter ended June 2025. Do…

Guardant Health at Goldman Sachs Conference: Strategic Growth Insights By Investing.com

Guardant Health at Goldman Sachs Conference: Strategic Growth Insights…

Why Guardant Health Stock Surged Nearly 9% Higher Today

Precision oncology specialist Guardant Health (NASDAQ: GH) was something of a stock market star on Tuesday. On the back of…

Guardant Health: A Promising Player in the Liquid Biopsy Market

Explore the exciting world of Guardant Health (NASDAQ: GH) with our expert analysts in this Motley Fool Scoreboard episode. Check…

Guardant Health: Tailwinds Are Beginning To Impact The Financials

…

Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates

Guardant Health (GH) delivered earnings and revenue surprises of 19.67% and 6.47%, respectively, for the quarter ended March 2025. Do…

Guardant Health: Die stille Revolution in der Krebsdiagnostik

Blutbasierte Krebsdiagnostik auf dem Weg zum neuen Standard – mit Milliardenpotenzial. Technologischer Vorsprung und KI-gestützte Plattform verschaffen Guardant Health…

Guardant Health shares rise on VA coverage for cancer test By Investing.com

Guardant Health shares rise on VA coverage for cancer test…

Colorectal Cancer Screening and Diagnostics Market Report 2025, with Profiles of Fujifilm, Olympus, Exact Sciences, Danaher, Guardant Health, Diacarta, Mainz Biomed, Novigenix and more

The Colorectal Cancer Screening and Diagnostics Market is set to grow from $40 billion in 2024 to $46.1 billion by…

Guardant Health: Vorreiter bei der Blutuntersuchung einzelner Krebsarten

Guardant Health ist ein Unternehmen für Präzisionsonkologie, das sich auf die Behandlung von Krebs durch umfangreiche Datensätze, proprietäre Bluttests…

2 Stocks Down 59% and 34% to Buy and Hold

Warren Buffett, arguably the greatest investor of all time, once said it is wise for investors to be fearful when…

Guardant Health, Inc. (GH) Q4 2024 Earnings Call Transcript

…

Guardant Health (GH) Reports Q4 Earnings: What Key Metrics Have to Say

The headline numbers for Guardant Health (GH) give insight into how the company performed in the quarter ended December 2024,…

Guardant Health, Inc. 2024 Q4 - Results - Earnings Call Presentation

…

Guardant Health Tops Q4 Revenue Forecast

The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.…

Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates

Guardant Health (GH) delivered earnings and revenue surprises of -24% and 0.98%, respectively, for the quarter ended December 2024. Do…

Guardant Health reports Q4 revenue beat, raises 2025 guidance By Investing.com

Guardant Health reports Q4 revenue beat, raises 2025 guidance…

Exploring Analyst Estimates for Guardant Health (GH) Q4 Earnings, Beyond Revenue and EPS

Looking beyond Wall Streets top -and-bottom-line estimate forecasts for Guardant Health (GH), delve into some of its key metrics to…

Guardant Health (GH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Guardant Health (GH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…

Guardant Health: Asymptomatic Screening Creating An Asymmetric Opportunity

…

Heres Why Guardant Health (GH) Is a Great Buy the Bottom Stock Now

After losing some value lately, a hammer chart pattern has been formed for Guardant Health (GH), indicating that the stock…

Guardant Health: Medicare-Abdeckung für Darmkrebs-Überwachung!

Guardant Health ist ein führendes Unternehmen im Bereich der Krebsdiagnostik, das sich auf Flüssigbiopsien spezialisiert hat. Mit innovativen Technologien ermöglicht…

Here Are the 6 Largest Stock Holdings in All of Cathie Woods ETFs Right Now

Asset management company Ark Invest offers nine different investment funds, eight of which are available as exchange-traded funds, or ETFs.…

Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?

Guardant Health (GH) saw its shares surge in the last session with trading volume being higher than average. The latest…

Guardant Health: Focused On Future Growth, Hold

…

Why Guardant Health Stock Blasted 13% Higher on Thursday

Theres nothing like news of a monster earnings and/or revenue beat to pump a stocks price higher. That was what…

Why Guardant Health Stock Just Crashed 10%

Guardant Health needs cash. Until it can get it from selling enough services, it must sell its own shares instead.…

Daqo New Energy, Guardant Health lower in premarket; SolarEdge, Xpeng gain By Investing.com

Daqo New Energy, Guardant Health lower in premarket; SolarEdge, Xpeng gain…

Global Cancer Biomarkers Market to Surge from USD 22.78 Billion in 2023 to USD 82.66 Billion by 2033, Achieving a CAGR of 13.76%

According to a research report published by Exactitude Consultancy, Companies covered:Abbott Laboratories Inc. - North America, Agilent Technologies Inc. -…

dpa-AFX ProFeed